Clinical Trial Information Request for Protocol 2025P000097 Title A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Iii Study To Evaluate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/Or Subacute Cutaneous Lupus Erythematosus Who Are Refractory And/Or Intolerant To Antimalarial Therapy PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone